| Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10289), 2049, 2021 | 311 | 2021 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial PW Horby, G Pessoa-Amorim, L Peto, CE Brightling, R Sarkar, K Thomas, ... Medrxiv, 2021 | 303 | 2021 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 235 | 2022 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 212 | 2021 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 197 | 2022 |
| Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group The Lancet Respiratory Medicine 9 (12), 1419-1426, 2021 | 145 | 2021 |
| Developing a core outcome set for patient-reported symptom monitoring to reduce hospital admissions for patients with heart failure CA Lawson, C Lam, T Jaarsma, U Kadam, A Stromberg, M Ali, WT Tay, ... European Journal of Cardiovascular Nursing 21 (8), 830-839, 2022 | 10 | 2022 |
| Changing health related quality of life and outcomes in heart failure by age, sex and subtype CA Lawson, L Benson, I Squire, F Zaccardi, M Ali, S Hand, U Kadam, ... eClinicalMedicine 64, 2023 | 6 | 2023 |
| Recognizing and responding to deterioration in care homes: a scoping review protocol SY Hodge, MR Ali, AL Gordon JBI Evidence Synthesis 19 (2), 447-453, 2021 | 5 | 2021 |
| Symptoms and signs in patients with heart failure: association with 3-month hospitalisation and mortality MR Ali, CSP Lam, A Strömberg, SPP Hand, S Booth, F Zaccardi, I Squire, ... Heart 110 (8), 578-585, 2024 | 4 | 2024 |
| Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Data Monitoring Committee of the RECOVERY ... Nature Communications 15 (1), 924, 2024 | 3 | 2024 |
| Racial and ethnic disparities in primary prevention of cardiovascular disease MR Ali, H Nacer, CA Lawson, K Khunti Canadian Journal of Cardiology, 2024 | 2 | 2024 |
| One year on—the persistent plight of the 2022 floods on health in Pakistan MR Ali, SW Javed, Z Iqbal, M Sartaj bmj 382, 2023 | 1 | 2023 |
| Patient-reported status and heart failure outcomes in Asia by sex, ethnicity, and socioeconomic status CA Lawson, WT Tay, M Richards, F Zaccardi, J Tromp, THK Teng, ... JACC: Asia 3 (3_Part_1), 349-362, 2023 | 1 | 2023 |
| Recognising and responding to acute deterioration in care home residents: a scoping review SY Hodge, MR Ali, A Hui, P Logan, AL Gordon | 1 | 2022 |
| Heart failure symptoms as predictors of hospital admission, readmission and all‐cause mortality MR Ali, SC Freeman, L Gray, U Kadam, C Lawson Cochrane Database of Systematic Reviews 2022 (10), 2022 | 1* | 2022 |
| Use of awake prone positioning in acute COVID-19 I Adejumo, MR Ali, M Sovani, DE Shaw European Respiratory Journal 60 (suppl 66), 2022 | | 2022 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10325), 665, 2022 | | 2022 |
Claire A LawsonAssociate Professor在 leicester.ac.uk 的电子邮件经过验证
